Cover Image

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hiba Jebeile, Yngvild Sørebø Danielsen, Priya Sumithran, Sasha Lorien, Isabelle R. Jardine, Louise A. Baur, Natalie B. Lister
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Obesity Reviews
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Components of Adolescent Behavioural Interventions With Eating Disorder Outcomes: Systematic Review With Intervention Mapping
by: Natalie B. Lister, et al.
Published: (2025)

Facets of Dietary Restraint Associated With Disordered Eating Behaviors Among Children and Adolescents With Higher Weight
by: Laura D'Adamo, et al.
Published: (2025)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
by: Hao Dai, et al.
Published: (2025)

Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
by: Binayak Sinha, et al.
Published: (2025)

Correction to ‘Changes in Eating Behaviour During Treatment With Obesity Medications’
Published: (2026)

Potential pathways to the onset and development of eating disorders in people with overweight and obesity: A scoping review
by: Rabia Khalid, et al.
Published: (2024)

Timing Matters: Early Eating Mitigates Genetic Susceptibility for Obesity
by: Divya Joshi, et al.
Published: (2025)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
by: Giorgia Rutigliani, et al.
Published: (2026)

Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
by: Roberta Scairati, et al.
Published: (2026)

Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
by: Mikhail Khachaturov, et al.
Published: (2026)

Glucagon‐Like Peptide‐1 Receptor Agonists: Considerations for Treating Preconception Obesity
by: Lauren T. Berube, et al.
Published: (2026)

A Randomized Effectiveness Trial of a Dissonance‐Based Dual Obesity and Eating Disorder Prevention Program
by: Eric Stice, et al.
Published: (2026)

Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
by: Jorge Urbina, et al.
Published: (2026)

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment
by: Joachim Holt, et al.
Published: (2025)

Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
by: Tahmid Hussain, et al.
Published: (2026)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
by: Inyoung Hwang, et al.
Published: (2026)

Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression
by: Muhammad Tahir, et al.
Published: (2026)

Reliability of the original and brief versions of the Eating Disorder Examination in binge‐eating disorder
by: Janet A. Lydecker, et al.
Published: (2024)

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP ‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes
by: Yazan Alhamdan, et al.
Published: (2026)

GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
by: Cynthia F. X. C. A. Silva, et al.
Published: (2026)

A Systematic Review and Meta‐Analytic Assessment of Unpredictability and Disordered Eating
by: Tomás Cabeza de Baca, et al.
Published: (2025)

Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis
by: Gabriel P. A. Costa, et al.
Published: (2025)

Obesity and Female Reproductive Health; Is There a Role for Glucagon‐Like Peptide‐1 Receptor Agonists?
by: Rachel Roberts, et al.
Published: (2025)

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP ‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials
by: Lucas Sabatella, et al.
Published: (2025)

Pilot Randomised Controlled Trial of the Feasibility and Acceptability of Family‐Based Time Limited Eating to Treat Obesity
by: Amy C. Gross, et al.
Published: (2026)

Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
by: Lasin Ozbek, et al.
Published: (2026)

Optimizing Obesity Management With GLP‐1 Agonist Medication Through Mobile Health Technology, Nutrition Therapy, and Progressive Strength Training: A Retrospective Program Review
by: Elizabeth Sharp Edens, et al.
Published: (2026)

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
by: Matheus Souza, et al.
Published: (2026)

GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
by: Jirawan Vienghirun, et al.
Published: (2026)

RETRACTION : Effects of GLP ‐1 Receptor Agonists on Cognitive Function in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis Based on Randomized Controlled Trials
Published: (2026)

Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes
by: Ying Lu, et al.
Published: (2025)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
by: Harold E. Bays, et al.
Published: (2026)

GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
by: Haisheng Wu, et al.
Published: (2026)

Unravelling the Ties: How Attachment Styles and Emotion Regulation Fuel Emotional Eating in Youth With Obesity—A Clinical Sample Study
by: Joana Gómez‐Odriozola, et al.
Published: (2026)

Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials
by: Rayanne Santos de Paulo, et al.
Published: (2026)

Identifying Predictors of Early Treatment Intensification in Individuals With Type 2 Diabetes Treated With GLP ‐1 Receptor Agonists: A Machine Learning–Based Analysis of a Large Real World Cohort
by: Pierpaolo Falcetta, et al.
Published: (2026)

Weight Loss With GLP ‐1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta‐Analysis
by: Michael Lim, et al.
Published: (2026)

The Impact of Eating Behaviors on Ultraprocessed Food Consumption Over 12 Months in Children
by: Dabin Yeum, et al.
Published: (2025)

Depressive symptoms at short‐, medium‐, and long‐term follow‐up after bariatric surgical procedures: A systematic review and meta‐analysis
by: Alyssa J. Budin, et al.
Published: (2025)

Effect of Behavioral Weight Management Interventions on Symptoms of Binge‐Eating Disorder and Bulimia Nervosa: A Systematic Review and Meta‐Analysis
by: Michael P. Berry, et al.
Published: (2026)